Blue Faery will host a free educational gathering on September 27, 2025, offering Dallas community members essential information about liver health and hepatocellular carcinoma (HCC). The HCC Lunch & Learn event will take place at Concord Church from 10 a.m. to 3 p.m., featuring presentations from UT Southwestern physicians and personal stories from individuals affected by liver cancer. The event aims to deliver critical knowledge on how liver disease and HCC develop, the role of multidisciplinary care teams, available community resources, and therapeutic options for both transplant-eligible and non-eligible patients.
Attendees aged 16 and over will receive a catered lunch while learning about disease prevention and treatment approaches from medical experts. President Andrea Wilson Woods emphasized the event's purpose, stating that the organization brings expert insight, real stories, and practical hope to the community through shared meals and knowledge exchange. Space for the event is limited, requiring advance registration through the organization's HCC Lunch & Learn registration page. This initiative represents an opportunity for Dallas residents to take proactive steps in understanding liver health, making informed healthcare decisions, and connecting with expert care and local support resources.
The event is part of Blue Faery's broader mission to prevent, treat, and cure primary liver cancer through research, education, and advocacy efforts. The organization maintains an online Liver Cancer Community for patients and caregivers and provides free comprehensive patient education materials, including Patient Resource Guides for Liver Cancer. The 2025 HCC Lunch & Learn event is made possible through sponsorship support from pharmaceutical companies AstraZeneca, Exelixis, and Merck. This educational gathering matters because it addresses significant health disparities in liver cancer outcomes by providing accessible, expert-led information to a community that may otherwise lack these resources.
The implications of this announcement extend beyond a single event, potentially influencing long-term health behaviors and early detection rates in the Dallas area. By combining medical expertise with personal narratives, the event creates a comprehensive understanding of hepatocellular carcinoma that can empower individuals to seek timely medical attention and make informed decisions about their health. The inclusion of both transplant-eligible and non-eligible patient information ensures that all community members receive relevant guidance regardless of their specific medical situation.
The partnership with UT Southwestern physicians lends medical credibility to the information presented, while the sponsorship from pharmaceutical companies demonstrates industry recognition of the importance of community education in liver cancer management. This event represents a model for how nonprofit organizations can bridge the gap between medical institutions and local communities, particularly for diseases like liver cancer where early detection and proper management significantly impact survival rates. The availability of these educational resources through Blue Faery's online platforms ensures that the impact extends beyond the physical event to reach a wider audience seeking liver cancer information.
